Gamma oryzanol niosomal gel for skin cancer: formulation and optimization using quality by design (QbD) approach

[1] Al Sabaa H(2018)Dapsone in topical niosomes for treatment of acne vulgaris Afr J Pharm Pharmacol 12 221-230

[2] Mady FM(2016)Hypolipidemic mechanism of oryzanol components-ferulic acid and phytosterols Biochem Biophys Res Commun 476 82-89

[3] Hussein AK(2018)Influence of processing methods on physico-mechanical properties of ibuprofen/HPC-SSL formulation Pharm Dev Technol 23 1108-1116

[4] Abdel-Wahab HM(2018)Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems Pharmaceutics. 10 57-18

[5] Ragaie MH(2020)Stabilization of ferulic acid in topical gel formulation via nanoencapsulation and pH optimization Sci Rep 10 1-211

[6] Bhaskaragoud G(2011)Lipid-mediated gene delivery to the skin Eur J Pharm Sci 43 199-24

[7] Rajath S(2014)Formulation of gammaoryzanol-loaded nanoparticles for potential application in fortifying food products Adv Pharm Bull 4 549-272

[8] Mahendra V(2003)Stability testing of new drug substances and products Q1A (R2), current step 4 1-154

[9] Kumar GS(2013)Niosomes as a propitious carrier for topical drug delivery Expert Opin Drug Deliv 10 261-ee72

[10] Krishna AG(2015)Lipid-based nano-delivery systems for skin delivery of drugs and bioactives Front Pharmacol 6 219-176

[1] Al Sabaa H(2018)Dapsone in topical niosomes for treatment of acne vulgaris Afr J Pharm Pharmacol 12 221-230

[2] Mady FM(2016)Hypolipidemic mechanism of oryzanol components-ferulic acid and phytosterols Biochem Biophys Res Commun 476 82-89

[3] Hussein AK(2018)Influence of processing methods on physico-mechanical properties of ibuprofen/HPC-SSL formulation Pharm Dev Technol 23 1108-1116

[4] Abdel-Wahab HM(2018)Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems Pharmaceutics. 10 57-18

[5] Ragaie MH(2020)Stabilization of ferulic acid in topical gel formulation via nanoencapsulation and pH optimization Sci Rep 10 1-211

[6] Bhaskaragoud G(2011)Lipid-mediated gene delivery to the skin Eur J Pharm Sci 43 199-24

[7] Rajath S(2014)Formulation of gammaoryzanol-loaded nanoparticles for potential application in fortifying food products Adv Pharm Bull 4 549-272

[8] Mahendra V(2003)Stability testing of new drug substances and products Q1A (R2), current step 4 1-154

[9] Kumar GS(2013)Niosomes as a propitious carrier for topical drug delivery Expert Opin Drug Deliv 10 261-ee72

[10] Krishna AG(2015)Lipid-based nano-delivery systems for skin delivery of drugs and bioactives Front Pharmacol 6 219-176